At the annual RuMSS conference, experts discussed changes to treatment made for reasons unrelated to a patient's clinical needs, such as procurement arrangements, logistics or budget pressures.
Yan Vlasov distinguished clinically justified changes from non-medical switching. Speakers stressed that treatment decisions should consider the course of the disease, effectiveness, tolerability and clinical recommendations.
Neurologist Ekaterina Novikova highlighted informed participation, adherence and trust between the patient and clinician. Igor Stepanov discussed the legal and ethical basis of this relationship, including informed consent and shared responsibility.
The participants called for stronger patient protection, a greater role for clinicians in treatment decisions and equitable access to therapy across regions. The publication reports the conference discussion rather than individual treatment advice.